Visitors
1010 Today
179774 Total
KATRD
LOGIN
- KATRD 2026 International Conference
-
October 29(Wed)-31(Fri), 2026 Lotte Hotel World, Seoul, Kore
- Program
Program at a Glance
Session in Korean (한국어 진행)| October 28 (Wed) | |||||||
|---|---|---|---|---|---|---|---|
| Time/Room | CRYSTAL 1 (3F) Room 1 |
CRYSTAL 2 (3F) Room 2 |
CRYSTAL 3 (3F) Room 3 |
EMERALD (3F) Room 4 |
PEARL (3F) Room 5 |
RUBY+JADE (3F) Room 6 |
SAPPHIRE (B1) Room 7 |
| 08:00-09:00 | Registration | ||||||
| 09:00-10:30 | Int'l Network Meeting 1 | Core Training Session 1 전공의 교육세션 1 |
Hands-on | Hands-on | Meet the Expert (09:00-10:00) |
Poster Exhibition | Meet the Expert (09:00-10:00) |
| TB Tuberculosis in Vulnerable Population: What Do We Know and What Should We Do? |
Bronchoscopy | Mechanical Ventilation | COPD | Lung Cancer Key Rare Mutations and Targeted Therapies in Lung Cancer |
|||
| Meet the Expert (10:00-11:00) |
Meet the Expert (10:00-11:00) |
||||||
| 10:30-12:00 | Int'l Network Meeting 2 | Core Training Session 2 전공의 교육세션 2 |
Asthma | ILD Emerging Therapies in ILD: Latest Clinical Trial Results |
|||
| Meet the Expert (11:00-12:00) |
|||||||
| Environmental Lung Disease Emerging Environmental Exposures and Lung Disease: Engineered Stone induced Pneumoconiosis and COPD |
Sleep | ||||||
| 12:00-13:30 | Break | ||||||
| 13:30-15:00 | Int'l Network Meeting 3 | Educational Session 1 한국어 교육세션 1 |
Int'l Network Meeting 4 | Healthcare Policy Priorities for Building a National COPD Care Continuum (13:30-15:30) 국가 COPD 전주기 관리체계 완성을 위한 보건의료 정책 과제 |
Epigenetics Session | ||
| Critical Care Medicine The Long and Winding Road: from ARDSNet, to PETAL, beyond COVID-19, and the Next? |
Lung cancer The Critical Debates on First-Line Treatment Strategies in Advanced Non-Small Cell Lung Cancer |
||||||
| 15:00-15:30 | Break | Break | |||||
| 13:30-15:00 | Int'l Network Meeting 5 | Educational Session 2 한국어 교육세션 2 |
PG Course ILD |
||||
| Airway Bridging Asthma and COPD: A New Era of Unified Airway Management |
|||||||
| 17:00-17:15 | Break | ||||||
| 17:15-18:15 | Satellite Symposium 01 | Satellite Symposium 03 | |||||
| Handok | ILDONG PHARMACEUTICAL CO.,LTD. | ||||||
| October 29 (Thu) | |||||||
|---|---|---|---|---|---|---|---|
| Time/Room | CRYSTAL 1 (3F) Room 1 |
CRYSTAL 2 (3F) Room 2 |
CRYSTAL 3 (3F) Room 3 |
EMERALD (3F) Room 4 |
PEARL (3F) Room 5 |
RUBY+JADE (3F) Room 6 |
SAPPHIRE (B1) Room 7 |
| [AI Translation] | |||||||
| 07:30-08:30 | Registration | Meet the Expert (07:30-08:30) |
Poster Exhibition | ||||
| 08:30-08:40 | Opening Ceremony | ||||||
| 08:40-10:10 | Plenary Session 1 | ||||||
| 10:10-10:30 | Break | ||||||
| 10:30-12:00 | Symposium 01 | Symposium 02 | Symposium 03 | Oral Presentation 01 | Oral Presentation 02 | Hands-on | |
| Airway 1 (COPD) ATS-KATRD Joint Symposium Unraveling COPD Complexity: Biology, Trajectories, and Biologics |
ILD 1 Updated ILD Guideline Session: What's Changed in ILD Classification and Management |
Bronchoscopy Updates in Interventional Pulmonology |
Thoracic Ultrasound KATRD TUS Training Course |
||||
| 12:00-12:30 | Luncheon Symposium 01 | Luncheon Symposium 02 | Luncheon Symposium 03 | Luncheon Symposium 04 | |||
| KOLON PHARMA |
Boehringer Ingelheim Korea |
AstraZeneca Korea Ltd. |
Sanofi Korea |
||||
| 12:30-13:30 | Break | ||||||
| 13:30-15:00 | Symposium 04 | Symposium 05 | Symposium 06 | Oral Presentation 03 | Oral Presentation 04 | Hands-on (13:30-15:30) |
|
| Airway 2 (Asthma) JRS-KATRD Joint Symposium |
Cough JRS-KATRD Joint Symposium Chronic Cough: Mechanisms, Measurement, and Management |
Environmental Lung Disease Novel Environmental Exposures and Emerging Approaches to Environmental Lung Diseases |
Thoracic Ultrasound KATRD TUS Scientific Session |
||||
| 15:00-15:30 | Break | ||||||
| 15:30-17:00 | Symposium 07 | Symposium 08 | Symposium 09 | Oral Presentation 05 | Oral Presentation 06 | ||
| Airway 3 (Bronchiectasis) Breaking the Vicious Vortex: From Guidelines to Pipeline |
Critical Care Medicine 1 Precision Medicine in ARDS |
Lung Cancer 1 Innovative milestones and techniques for bench to bedside transition in Lung Cancer |
|||||
| 17:00-17:15 | Break | ||||||
| 17:15-18:15 | Satellite Symposium 05 | Satellite Symposium 06 | Satellite Symposium 07 | Satellite Symposium 08 | |||
| GSK | MSD Korea | AstraZeneca Korea Ltd. |
KOLON PHARMA |
||||
| October 30 (Fri) | |||||||
|---|---|---|---|---|---|---|---|
| Time/Room | CRYSTAL 1 (3F) Room 1 |
CRYSTAL 2 (3F) Room 2 |
CRYSTAL 3 (3F) Room 3 |
EMERALD (3F) Room 4 |
PEARL (3F) Room 5 |
RUBY+JADE (3F) Room 6 |
SAPPHIRE (B1) Room 7 |
| [AI Translation] | |||||||
| 07:30-08:30 | Registration | Poster Exhibition | |||||
| 08:30-10:00 | Plenary Session 2 | ||||||
| 10:00-10:20 | Break | ||||||
| 10:20-11:50 | Symposium 10 | Symposium 11 | Symposium 12 | Report of KATRD Research Grant (10:20-11:20) 연구비 발표 |
Oral Presentation 07 | Oral Presentation 10 | |
| NTM Managing NTM-PD: What Should We Focus on? |
Critical Care Medicine 2 Updated ILD Guideline Session: What's Changed in ILD Classification and Management |
Lung Cancer 2 Future Directions of Critical Care in Asia Pacific |
|||||
| 11:50-12:20 | Luncheon Symposium 05 | Luncheon Symposium 06 | Luncheon Symposium 07 | Luncheon Symposium 08 | |||
| Handok | GSK | YUHAN. Co. | Daewon Phamaceutical |
||||
| 12:20-13:30 | Break | ||||||
| 13:30-14:30 | KATRD General Assembly *Members Only |
||||||
| 14:30-14:40 | Break | ||||||
| 14;40-16:10 | Symposium 13 | Symposium 14 | Symposium 15 | Symposium 16 | Oral Presentation 08 | Oral Presentation 11 | |
| Airway 4 (COPD) APSR-KATRD Joint Symposium Beyond Pharmacologic Therapy in COPD: Multimodal Assessment and Digital Integration |
ILD 2 Beyond the Common: Rare Interstitial Lung Diseases |
Pulmonary Vascular Disease | Practical Tuberculosis Course for Primary Care Physicians 1 우리나라 결핵의 현주소와 미래 발전 방향 |
||||
| 16:10-16:20 | Break | ||||||
| 16:20-17:50 | Symposium 17 | Symposium 18 | Symposium 19 | Symposium 20 | Oral Presentation 09 | Oral Presentation 12 | |
| Sleep Moving Toward Precision Medicine in OSA |
Infection | MTS-KATRD Joint Symposium Hospital-Acquired Pneumonia 2026: Multicenter Real-World Evidence and Management Strategies for MDR-GNB |
Practical Tuberculosis Course for Primary Care Physicians 2 결핵 진단, 치료의 최신 업데이트 |
||||